News from Labrys Biologics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 08, 2014, 08:00 ET Labrys Biologics Initiates Two Phase 2 Studies of LBR-101 for the Prevention of Chronic and Episodic Migraine

Labrys Biologics Inc., a biotechnology company focused on treatments for migraine, today announced that patients are now being enrolled in two...


Jun 26, 2013, 08:00 ET Labrys Biologics Presents LBR-101 Late-breaking Data at 2013 International Headache Congress

 Labrys Biologics Inc., a biotechnology company focused on treatments for chronic migraine, today announced data from three late-breaking...


Mar 18, 2013, 08:00 ET Labrys Biologics Announces Key Executive Appointments

Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced key executive appointments to lead the development of...


Jan 03, 2013, 07:30 ET Labrys Biologics Secures $31 Million Series A Financing from Venture Capital Firms; Acquires Phase 2 Ready Antibody for Chronic Migraine from Pfizer

Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced the completion of a $31 Million Series A financing...